N@N

CACB, FOLD, NOVA, LB, ACU Expected To Be Lower After Earnings Releases on Thursday

^{Published on 2009-10-27 10:26:39, Last Modified on 2010-12-22 17:20:41 - WOPRAI}
 

October 27, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 29th and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and September earnings reports. Cascade Bancorp (NASDAQ: CACB), Amicus Therapeutics (NASDAQ: FOLD), NovaMed (NASDAQ: NOVA), LaBarge (NYSE: LB) and Acme United (NYSE: ACU) are all expected to be lower after their earnings are released Thursday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower after earnings are released Thursday:

Symbol Company # of Reports Quarter Release Time

CACB Cascade Bancorp Inc. 12 quarters Q3 Before

FOLD Amicus Therapeutics 12 quarters Q3 After

NOVA NovaMed Inc. 12 quarters Q3 Before

LB LaBarge, Inc. 12 quarters Q1 Before

ACU Acme United Corp. October earnings Q3 Before

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Cascade Bancorp (NASDAQ: CACB) operates as the holding company for Bank of the Cascades that provides a range of commercial and retail banking services. It primarily engages in generating deposits and originating loans. The companya�s deposit products comprise checking, savings, money market, and time deposit accounts. Its loan portfolio includes commercial real estate loans, real estate construction and development loans, commercial and industrial loans, and residential mortgage loans, as well as consumer installment, line-of-credit, credit card, and home equity loans. In addition, the company provides cash management, investment and trust related services, Internet banking, electronic bill payment services, and automated teller machines and safe deposit facilities. It serves small to medium-sized businesses, municipalities and public organizations, and professional and consumer relationships. As of December 31, 2008, Cascade Bancorp operated 33 branches, including 11 in Central Oregon, 3 in the Salem/Keizer area, 6 in Southern Oregon, 1 in Portland, and 12 branches in the greater Boise area. The company was founded in 1977 and is headquartered in Bend, Oregon.

Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs, known as pharmacological chaperones, for the treatment of various human genetic diseases. Pharmacological chaperones selectively bind to the target protein, increase the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. It is primarily targeting lysosomal storage disorders, which are severe, chronic genetic diseases. The companya�s products include Amigal, which has completed Phase II clinical trial for the treatment of Fabry disease; Plicera, a Phase II clinical trial product for the treatment of Gaucher disease; and AT2220, a Phase II clinical trial product for the treatment of Pompe disease. Amicus Therapeutics has a strategic collaboration with Shire Pharmaceuticals Ireland Ltd. to jointly develop three lead pharmacological chaperone compounds for lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.

NovaMed, Inc. (NASDAQ: NOVA), a health care services company, engages in the ownership and operation of ambulatory surgery centers (ASCs) in joint ownership with physicians in the United States. The companya�s physicians perform various surgical procedures in the areas of ophthalmology, pain management, gastroenterology, urology, otolaryngology (ENT), plastic surgery, and gynecology, as well as in the area of orthopedics, including podiatry. It also provides excimer lasers and other services to ophthalmologists for their use in performing laser vision correction surgery. In addition, the company owns and operates optical laboratories, which manufacture and distribute corrective lenses and eyeglasses to both affiliated and non-affiliated ophthalmologists and optometrists; an optical products purchasing organization; and a marketing products and services business, which provides a range of products and services, including brochures, videos, advertising and Web site design, education and training programs, and consulting services for eye care professionals and vendors. Further, NovaMed offers management services to eye care practices pursuant to long-term service agreements. As of March 15, 2009, it owned and operated 37 ASCs in 19 states. The company was formerly known as NovaMed Eyecare, Inc. and changed its name to NovaMed, Inc. in March 2004. NovaMed was founded in 1995 and is based in Chicago, Illinois.

LaBarge, Inc. (NYSE: LB), a contract manufacturer, provides electronic and electromechanical systems and devices, and interconnect systems for customers in the defense, government systems, medical, aerospace, natural resources, industrial, and other commercial markets in the United States. The company manufactures, engineers, and designs interconnect systems, printed circuit board assemblies, high-level assemblies, and electronic systems. It produces electronic equipment for use in various high-technology applications, including military communication, radar, and weapons systems; industrial automation; military and commercial aircraft; satellites; space launch vehicles; oil and gas wells; mine automation equipment; and medical devices. The company was founded in 1950 and is based in St. Louis, Missouri.

Acme United Corporation (NYSE: ACU), together with its subsidiaries, supplies cutting, measuring, and safety products to the school, home, office, and industrial markets in the United States, Canada, Europe, and Asia. Its cutting device products include scissors, shears, guillotine paper trimmers, rotary paper trimmers, rotary cutters, hobby knives and blades, chef shears, utility knives, manicure products, medical cutting instruments, and pencil sharpeners. The companya�s measuring instrument products comprise rulers, math tools, and tape measures. Its safety products include first aid kits, personal protection products, and over-the-counter medication refills. The company markets its products primarily under the Westcott, Clauss, and PhysiciansCare brands. Acme United Corporation distributes its products through independent manufacturer representatives and direct sales forces to wholesale, contract, and retail stationery distributors, office supply super stores, school supply distributors, industrial distributors, wholesale florists, mass market retailers, and hardware chains. The company was founded in 1867 and is headquartered in Fairfield, Connecticut.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641